178 related articles for article (PubMed ID: 24908063)
21. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
Lu K; Chiu KY
Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
[TBL] [Abstract][Full Text] [Related]
22. Solid Organ Cancer and Melanoma in Kidney Transplant Recipients: TumorTx Base Preliminary Results.
Lizakowski S; Kolonko A; Imko-Walczuk B; Komorowska-Jagielska K; Rutkowski B; Więcek A; Dębska-Ślizień A
Transplant Proc; 2018; 50(6):1881-1888. PubMed ID: 30056921
[TBL] [Abstract][Full Text] [Related]
23. Posttransplant malignancies in renal transplant recipients: 22-years experience from a single center in Pakistan.
Yunus M; Aziz T; Mubarak M
Asian Pac J Cancer Prev; 2012; 13(2):575-8. PubMed ID: 22524827
[TBL] [Abstract][Full Text] [Related]
24. Malignancy in renal recipients.
Samhan M; Al-Mousawi M; Donia F; Fathi T; Nasim J; Nampoory MR
Transplant Proc; 2005 Sep; 37(7):3068-70. PubMed ID: 16213307
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
Gutierrez-Dalmau A; Campistol JM
Drugs; 2007; 67(8):1167-98. PubMed ID: 17521218
[TBL] [Abstract][Full Text] [Related]
26. Malignancy Prevalence in Waitlisted Potential Kidney Transplant Recipients Is Very Low Relative to Patients After Kidney Transplantation.
Pyrża M; Małyszko J; Żebrowski P; Wieliczko M; Małyszko J
Transplant Proc; 2020 Oct; 52(8):2264-2267. PubMed ID: 32362461
[TBL] [Abstract][Full Text] [Related]
27. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
28. Postrenal transplant malignancy: Incidence, risk factors, and prognosis.
Elserwy NA; Lotfy EE; Fouda MA; Mahmoud MI; Donia AF; Mashaly ME; Abbas MH; Abuelmagd MM; Abouelenein RK; Ismail MI; Bakr MA
Saudi J Kidney Dis Transpl; 2017; 28(3):579-588. PubMed ID: 28540896
[TBL] [Abstract][Full Text] [Related]
29. Malignancies after kidney transplantation: a 40-year single-center experience in Korea.
Hwang JK; Moon IS; Kim JI
Transpl Int; 2011 Jul; 24(7):716-21. PubMed ID: 21575081
[TBL] [Abstract][Full Text] [Related]
30. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
31. A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience.
Zhang A; Shang D; Zhang J; Zhang L; Shi R; Fu F; Tian Y
World J Urol; 2015 May; 33(5):713-7. PubMed ID: 25239501
[TBL] [Abstract][Full Text] [Related]
32. Malignancy in renal transplant recipients at king hussein medical center.
Al-Akash N; Gneimat M; Hadidi M; El Lozi M
Saudi J Kidney Dis Transpl; 1995; 6(4):400-2. PubMed ID: 18583747
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of human herpes virus-8 in renal transplant recipients: a single center study from Iran.
Ahmadpoor P; Ilkhanizadeh B; Sharifzadeh P; Makhdoomi K; Ghafari A; Nahali A; Yekta Z; Noroozinia F
Transplant Proc; 2007 May; 39(4):1000-2. PubMed ID: 17524874
[TBL] [Abstract][Full Text] [Related]
34. Pre-transplant malignancy is associated with increased risk of de novo malignancy post-lung transplantation.
Sekowski V; Jackson K; Halloran K; Varughese R; Nagendran J; Weinkauf J; Lien D; Hirji A
Respir Med; 2022 Jun; 197():106855. PubMed ID: 35483168
[TBL] [Abstract][Full Text] [Related]
35. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia.
Qunibi W; Al-Furayh O; Almeshari K; Lin SF; Sun R; Heston L; Ross D; Rigsby M; Miller G
Transplantation; 1998 Feb; 65(4):583-5. PubMed ID: 9500639
[TBL] [Abstract][Full Text] [Related]
36. Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease.
Jorgenson MR; Descourouez JL; Singh T; Astor BC; Panzer SE
Pharmacotherapy; 2018 Jan; 38(1):51-57. PubMed ID: 29136299
[TBL] [Abstract][Full Text] [Related]
37. Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group.
O'Neill JP; Sexton DJ; O'Leary E; O'Kelly P; Murray S; Deady S; Daly F; Williams Y; Dean B; Fitzgerald C; Murad A; Mansoor N; O'Neill JO; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Little D; Moloney FJ; Conlon PJ
Clin Transplant; 2019 Oct; 33(10):e13669. PubMed ID: 31310037
[TBL] [Abstract][Full Text] [Related]
38. De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years.
Zavos G; Moris D; Kostakis ID; Vernadakis S; Bokos J; Zavvos V; Lionaki S; Boletis J
Exp Clin Transplant; 2015 Aug; 13(4):313-8. PubMed ID: 26295181
[TBL] [Abstract][Full Text] [Related]
39. Trends in Kaposi's Sarcoma Morbidity: A Retrospective Cohort Study of Heart and Lung Transplant Recipients.
Serlin T; Ben Gal T; Kramer MR; Sorin D; Hodak E; Davidovici B
Acta Derm Venereol; 2021 Aug; 101(8):adv00528. PubMed ID: 34405248
[TBL] [Abstract][Full Text] [Related]
40. Low incidence of malignancy after transplantation in Chinese heart allograft recipients.
Hsu RB; Chen RJ; Chou NK; Ko WJ; Wang SS; Chu SH
Transpl Int; 2005 Mar; 18(3):283-8. PubMed ID: 15730487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
